引用本文:
【打印本页】   【下载PDF全文】   View/Add Comment  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 422次   下载 510 本文二维码信息
码上扫一扫!
分享到: 微信 更多
B淋巴细胞参与微小病变型肾病发病机制的研究进展
邢雪琪,王 妍,何伟春
南京医科大学第二附属医院肾脏病中心,南京 210000
摘要:
[摘要] 微小病变型肾病(MCD)是一种肾小球疾病,其在光镜下肾小球病变表现轻微,常缺乏免疫复合物沉积,而电镜下特征性表现为弥漫性足突融合。既往研究多认为该病与T淋巴细胞功能障碍密切相关。然而,近年来的研究发现,B淋巴细胞耗竭剂利妥昔单抗可诱导MCD缓解,提示了B淋巴细胞在MCD发生、发展中可能发挥着重要作用。该文对B淋巴细胞参与MCD发病机制的研究进展作一综述。
关键词:  微小病变型肾病  B淋巴细胞  利妥昔单抗  自身抗体  细胞因子
DOI:10.3969/j.issn.1674-3806.2025.10.20
分类号:R 692
基金项目:国家自然科学基金项目(编号:31571169)
Research progress in involvement of B lymphocytes in pathogenesis of minimal change disease
XING Xueqi, WANG Yan, HE Weichun
Center for Kidney Diseases, the Second Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China
Abstract:
[Abstract] Minimal change disease(MCD) is a glomerular disease characterized by mild glomerular lesions under light microscopy, often lacking immune complex deposition, but characterized by diffuse foot process fusion under electron microscopy. Previous studies have generally believed that this disease is closely related to T lymphocyte dysfunction. However, recent studies have found that the depletion agent of B lymphocytes, rituximab(RTX), can induce remission of MCD, suggesting that B lymphocytes may play an important role in the occurrence and development of MCD. In this paper, the research progress in involvement of B lymphocytes in pathogenesis of MCD is reviewed.
Key words:  Minimal change disease(MCD)  B lymphocytes  Rituximab(RTX)  Autoantibodies  Cytokines